NCT00001393View on ClinicalTrials.gov

Genetic Markers for Focal Segmental Glomerulosclerosis

CompletedOBSERVATIONAL
Enrollment

616

Participants

Timeline

Start Date

April 15, 1996

Conditions
Focal Segmental GlomerulosclerosisHIV-Associated Focal Segmental Glomerulosclerosis
Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00001393 - Genetic Markers for Focal Segmental Glomerulosclerosis | Biotech Hunter | Biotech Hunter